Incyte Corp. (INCY)
120.39
+3.59
(+3.07%)
USD |
NASDAQ |
Oct 30, 16:00
120.38
-0.01
(-0.01%)
After-Hours: 20:00
Incyte 30-Day Average Daily Volume : 1.814M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.814M |
| October 29, 2026 | 1.842M |
| October 28, 2026 | 1.790M |
| October 27, 2026 | 1.774M |
| October 26, 2026 | 1.752M |
| October 23, 2026 | 1.725M |
| October 22, 2026 | 1.723M |
| October 21, 2026 | 1.698M |
| October 20, 2026 | 1.694M |
| October 19, 2026 | 1.692M |
| October 16, 2026 | 1.687M |
| October 15, 2026 | 1.665M |
| October 14, 2026 | 1.678M |
| October 13, 2026 | 1.655M |
| October 12, 2026 | 1.618M |
| October 09, 2026 | 1.609M |
| October 08, 2026 | 1.595M |
| October 07, 2026 | 1.558M |
| October 06, 2026 | 1.554M |
| October 05, 2026 | 1.499M |
| October 02, 2026 | 1.479M |
| October 01, 2026 | 1.447M |
| September 30, 2026 | 1.421M |
| September 29, 2026 | 1.407M |
| September 28, 2026 | 1.418M |
| Date | Value |
|---|---|
| September 25, 2026 | 1.396M |
| September 24, 2026 | 1.383M |
| September 23, 2026 | 1.372M |
| September 22, 2026 | 1.357M |
| September 21, 2026 | 1.347M |
| September 18, 2026 | 1.356M |
| September 17, 2026 | 1.312M |
| September 16, 2026 | 1.323M |
| September 15, 2026 | 1.347M |
| September 14, 2026 | 1.342M |
| September 11, 2026 | 1.355M |
| September 10, 2026 | 1.395M |
| September 09, 2026 | 1.444M |
| September 08, 2026 | 1.598M |
| September 04, 2026 | 1.646M |
| September 03, 2026 | 1.651M |
| September 02, 2026 | 1.653M |
| September 01, 2026 | 1.609M |
| August 31, 2026 | 1.633M |
| August 28, 2026 | 1.625M |
| August 27, 2026 | 1.659M |
| August 26, 2026 | 1.681M |
| August 25, 2026 | 1.707M |
| August 24, 2026 | 1.711M |
| August 21, 2026 | 1.734M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Regeneron Pharmaceuticals, Inc. | 753586.4 |
| Mirum Pharmaceuticals, Inc. | 763272.6 |
| AbbVie, Inc. | 4.796M |
| Alnylam Pharmaceuticals, Inc. | 1.861M |
| Biogen, Inc. | 1.299M |